| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521436 Modified phosphocalcic compound, injectable composition containing same |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521053 Angiopoietin-2 specific binding agents |
| 04/21/2009 | US7521052 Administering an effective amount of an anti-IL-6 receptor antibody (anti-IL-6R antibody) and an effective amount of methotrexate (MTX) for therapy of rheumatoid arthritis |
| 04/21/2009 | CA2400317C Improved paste formulations |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2299420C Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 04/16/2009 | WO2009049183A1 Aryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | WO2009049181A1 Amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | WO2009048072A1 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15 |
| 04/16/2009 | WO2009047903A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | WO2009047356A1 Compositions and methods for use for antibodies against sclerostin |
| 04/16/2009 | WO2009026334A3 Treatment with kallikrein inhibitors |
| 04/16/2009 | WO2009020234A3 Pyrrolidin-2 -one derivatives as androgen receptor modulator |
| 04/16/2009 | WO2008067027A3 Compositions of chkl inhibitors and cyclodextrin |
| 04/16/2009 | WO2007011674A3 Compositions and methods for treating and preventing inflammatory and/or degenerative processes in humans and other animals |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | US20090099268 Anti-adhesion membrane |
| 04/16/2009 | US20090099261 Omega-3 mixtures |
| 04/16/2009 | US20090099237 Methods of treating inflammatory diseases |
| 04/16/2009 | US20090099190 Kinase inhibitors useful for the treatment of proliferative diseases |
| 04/16/2009 | US20090099185 P38 Map Kinase Inhibitors |
| 04/16/2009 | US20090099181 Sulfoximines as kinase inhibitors |
| 04/16/2009 | US20090099172 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES |
| 04/16/2009 | US20090099156 Heterocyclic Compounds as Ccr2b antagonists |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090099100 Compositions and methods for treating amyloidosis |
| 04/16/2009 | US20090099089 administering to the site of the full thickness defect of articular cartilage, an osteochondral graft , an active growth factor e.g. purified bone morphogenetic protein (BMP) and a suitable carrier for the regeneration of the cartilage |
| 04/16/2009 | US20090099084 Treatment |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098229 Method of treating osteoporosis with extract of dioscorea sp. |
| 04/16/2009 | US20090098216 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 04/16/2009 | US20090098204 Tissue implants and methods for making and using same |
| 04/16/2009 | US20090098177 Methods and devices for tissue repair |
| 04/16/2009 | US20090098175 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 04/16/2009 | US20090098092 Composite Bone Material and Method of Making and Using Same |
| 04/16/2009 | DE102008009752A1 Beverage for improving the state of health, contains chili pepper juice and grape fruit juice that are mixed to the beverage without alcohol |
| 04/16/2009 | CA2702190A1 Injectable radio-opaque compositions for tissue augmentation |
| 04/16/2009 | CA2702101A1 Aryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | CA2702005A1 Compositions and methods for use for antobodies against sclerostin |
| 04/16/2009 | CA2701880A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | CA2701766A1 Amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | CA2698326A1 Antibody targeting osteoclast-related protein siglec-15 |
| 04/15/2009 | EP2048163A1 Antihuman alpha- 9 integrin antibody and use of the same |
| 04/15/2009 | EP2048150A1 Benzyl phenyl glucopyranoside derivative |
| 04/15/2009 | EP2047863A1 Preventive or remedy for inflammatory disease |
| 04/15/2009 | EP2046798A1 Furo [3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 04/15/2009 | EP2046797A1 Furo [3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 04/15/2009 | EP2046796A1 Tetrahydrofuro [3, 2 -b]pyrr0l-3-ones as cathepsin k inhibitors |
| 04/15/2009 | EP2046795A1 Furo[3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 04/15/2009 | EP2046791A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 04/15/2009 | EP2046787A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 04/15/2009 | EP2046737A2 2-methylene-1 alpha,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 04/15/2009 | EP2046723A2 Phenylacetic acid derivatives as cox-2 inhibitors |
| 04/15/2009 | EP2046382A2 scFv ANTIBODIES WHICH PASS EPITHELIAL AND/OR ENDOTHELIAL LAYERS |
| 04/15/2009 | EP2046350A2 Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis |
| 04/15/2009 | EP2046349A1 Treatment of excessive neovascularization |
| 04/15/2009 | EP2046332A2 Concentrated methotrexate solutions |
| 04/15/2009 | EP2046312A2 Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 04/15/2009 | EP1551763B1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 04/15/2009 | EP1437140B1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 04/15/2009 | EP1419143B1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 04/15/2009 | EP1417307B1 Oligonucleotide compositions and their use to induce apoptosis |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1244648B1 Chemokine receptor binding heterocyclic compounds |
| 04/15/2009 | EP1203007B1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) and its receptor c-met |
| 04/15/2009 | EP1043317B1 Pyridazine derivatives and medicaments containing them as active ingredient |
| 04/15/2009 | EP0792292B2 Estrogen receptor |
| 04/15/2009 | CN101410376A Piperazinyl derivatives as modulators of chemokine receptor activity |
| 04/15/2009 | CN101410132A GDF-9/BMP-15 modulators for the treatment of bone disorders |
| 04/15/2009 | CN101407812A Heterologous expression and purification method for human RANTES protein having chemotaxis |
| 04/15/2009 | CN101407796A Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 04/15/2009 | CN101407546A Human anti-human tumor necrosis factor-alpha single chain antibody |
| 04/15/2009 | CN101406694A Formulation for increasing bone density and preparation thereof |
| 04/15/2009 | CN101406691A Melittin complex nanometer granule for oral dosing and preparation method thereof |
| 04/15/2009 | CN101406688A Compound formulation for treating rheumatic arthritis and rheumatoid arthritis |
| 04/15/2009 | CN101406655A Chinese medicinal composition for treating lumbar and cervical vertebra disease |
| 04/15/2009 | CN101406646A Chinese medicinal liquor for treating arthritis |
| 04/15/2009 | CN101406645A Chinese medicinal composition for hyperosteogeny |
| 04/15/2009 | CN101406633A Pellet for recuperation of neck and waist |
| 04/15/2009 | CN101406632A Medicament for treating rheumatism and rheumatoid and preparation thereof |
| 04/15/2009 | CN101406622A Chinese-medicinal wine for treating rheumatism and arthralgia |
| 04/15/2009 | CN101406606A Plaster for treating rheumatism paralysis, hyperosteogeny and aches of neck, shoulder, waist and leg |
| 04/15/2009 | CN101406595A Liquor for treating lumbar interveterbral disc protrusion rheumatism |
| 04/15/2009 | CN101406590A Chinese medicinal composition for treating rheumatism osteonosus and preparation method |
| 04/15/2009 | CN101406588A Externally appiled chinese medicine for treating bone tuberculosis |
| 04/15/2009 | CN101406586A External-use Chinese medicine preparation for treating soft tissue injury and scapulohumeral periarthritis, and preparation method thereof |
| 04/15/2009 | CN101406585A Chinese medicine capsule for treating ischemic femoral head necrosis |
| 04/15/2009 | CN101406584A Agent for treating gout |
| 04/15/2009 | CN101406582A Stype for treating femoral head necrosis and preparation method thereof |
| 04/15/2009 | CN101406581A Ostalgia plaster |
| 04/15/2009 | CN101406568A External use medicament for treating protrusion of lumbar vertebral disc |
| 04/15/2009 | CN101406565A Pepper Babu plaster for rheumatism and method for producing the same |
| 04/15/2009 | CN101406561A Medicine for treating rheumatic diseases |